PALO ALTO INVESTORS
Palo Alto Investors is an investment advisory company that provides money management services. It also operates as a private investment firm that offers long-term investments for high-net-worth and institutional investors based on original and fundamental research. Palo Alto Investors was founded in 1989 and is based in Palo Alto, California.
PALO ALTO INVESTORS
Industry:
Advice Finance Venture Capital
Founded:
1989-01-01
Status:
Active
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Microsoft Exchange Online Office 365 Mail Google Maps Microsoft Azure DNS Google Maps API ASP.NET
Similar Organizations
Raven Capital
Raven Capital is an investment manager providing asset management and family office services.
Current Employees Featured
Charles Cho
Charles Cho Managing Director @ Palo Alto Investors Managing Director 2008-01-01
Alvin Tam
Alvin Tam Head Trader @ Palo Alto Investors Head Trader 2006-01-01
Jennifer Trailer
Jennifer Trailer Office Manager @ Palo Alto Investors Office Manager
John Doux
John Doux Managing Director @ Palo Alto Investors Managing Director 2004-01-01
Joon Yun
Joon Yun Co-Managing Member & President @ Palo Alto Investors Co-Managing Member & President 1998-01-01
Will Edwards
Will Edwards Founder @ Palo Alto Investors Founder 1989-01-01
Kai Wu
Kai Wu Controller @ Palo Alto Investors Controller 2013-01-01
Karen Trailer
Karen Trailer Chief Administrative Officer & Office Manager @ Palo Alto Investors Chief Administrative Officer & Office Manager 1994-06-01
Patrick Lee
Patrick Lee Co-Managing Member & Analyst @ Palo Alto Investors Co-Managing Member & Analyst 2001-01-01
Diana Vo
Diana Vo Investor Relations Manager & Director Of Operations @ Palo Alto Investors Investor Relations Manager & Director Of Operations 2013-06-01
Founder
Will Edwards
Investments List
Date | Company | Article | Money raised |
---|---|---|---|
2021-05-06 | Gilgamesh Pharmaceuticals | Palo Alto Investors investment in Series A - Gilgamesh Pharmaceuticals | 27 M USD |
2014-09-15 | NewLeaf Symbiotics | Palo Alto Investors investment in Series B - NewLeaf Symbiotics | 17 M USD |
2014-01-02 | NeXeption | Palo Alto Investors investment in Series A - NeXeption | 21.5 M USD |
2012-07-18 | Alimera Sciences | Palo Alto Investors investment in Post-IPO Equity - Alimera Sciences | 40 M USD |
2012-06-05 | Ceptaris Therapeutics | Palo Alto Investors investment in Series D - Ceptaris Therapeutics | 10 M USD |
2011-08-11 | Ceptaris Therapeutics | Palo Alto Investors investment in Series D - Ceptaris Therapeutics | 14.4 M USD |
2011-06-10 | Revance Therapeutics | Palo Alto Investors investment in Series D - Revance Therapeutics | 45 M USD |
2011-02-22 | Fisker Automotive | Palo Alto Investors investment in Private Equity Round - Fisker Automotive | 150 M USD |
2009-12-28 | Revance Therapeutics | Palo Alto Investors investment in Series D - Revance Therapeutics | 25.62 M USD |
2008-09-09 | Fisker Automotive | Palo Alto Investors investment in Series C - Fisker Automotive | 65 M USD |